COLLIN RADER: Open Payments
NPI 1831369222 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $259 |
| Amgen Inc. | 2 | $248 |
| GENZYME CORPORATION | 1 | $34 |
| Novo Nordisk Inc | 1 | $23 |
Products named: Bimzelx, KRYSTEXXA, TAVNEOS, KEVZARA, Ozempic.
Industry payments across TX — which companies pay providers there.
